14 February 2018 - Growth is slowing dramatically, but the political pressure isn't.

Pharma's pricing power just isn't what it used to be, and it's probably not going to recover any time soon.

Pharmacy benefit manager Express Scripts last week reported a record-low 1.5% increase in drug spending by commercial health insurance plans in 2017. It also said per-beneficiary drug spending fell for many commercial plans and gave a discouraging forecast -- for drugmakers, anyway -- for the years ahead.

Read Bloomberg article